FDA NDC

Tymlos

This name is from the loaded FDA file.

Source: FDA NDC Directory, live from openFDA. Publisher page

NDC
70539-001
Proprietary name
Tymlos
Nonproprietary name
abaloparatide
Labeler
Radius Health, Inc.
Dosage form
INJECTION, SOLUTION
Strength
3.12 mg/1.56mL

Run it in Rivvi

Which 2027 plans near you dropped or restricted abaloparatide?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Try it on your own data today.

Free to start. Most teams are using it the same day.